Insider screener

Period: 12 months Role: Other officers × Plan: Scheduled (10b5-1) × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

10,581 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

10,581 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

10,581 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

10,581 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
10,581 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
10,581 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

10,581 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
4 Feb 2026
Ogilby Gary A Senior VP & Corp Controller
Sold on a plan
$272.55K 435 at 626.56
12.0%
Planned (10b5-1)
4 Feb 2026
Burnett Patrick See Remarks
Sold on a plan
$252.75K 9,794 at 25.81
10.8%
Planned (10b5-1)
4 Feb 2026
Middleton Hunter Chief Product Officer
Sold on a plan
$212.81K 85,044 at 2.50
11.5%
Planned (10b5-1)
4 Feb 2026
FISHER ERIKA ASHLEY Chief Legal Officer
Sold on a plan
$200.17K 841 at 238.01
7.7%
Planned (10b5-1)
4 Feb 2026
Howton David T Chief Operating Officer
Sold on a plan
$121.71K 18,894 at 6.44
16.2%
Planned (10b5-1)
4 Feb 2026
Sold on a plan
$107.99K 10,000 at 10.80
0.5%
Planned (10b5-1)
4 Feb 2026
REED ELIZABETH E Chief Legal Officer and GC
Sold on a plan 2×
$96.36K 2,994 at 32.18
2.8%
Planned (10b5-1)
4 Feb 2026
Brooks Gabriel Chief Medical Officer
Sold on a plan
$81.27K 12,616 at 6.44
13.0%
Planned (10b5-1)
4 Feb 2026
Hanrahan Jessie Chief Regulatory Officer
Sold on a plan
$79.54K 12,348 at 6.44
14.9%
Planned (10b5-1)
4 Feb 2026
Herzich Paul Chief Technology Officer
Sold on a plan
$70.25K 10,905 at 6.44
13.6%
Planned (10b5-1)
4 Feb 2026
Inrig Jula CHIEF MEDICAL OFFICER
Sold on a plan 2×
$57.30K 1,779 at 32.21
1.7%
Planned (10b5-1)
4 Feb 2026
WESTBROOKS KRISTOPHER R President & COO
Sold on a plan
$45.28K 2,128 at 21.28
1.1%
Planned (10b5-1)
4 Feb 2026
Sellers Jeanette SVP of Accounting
Sold on a plan
$39.84K 2,182 at 18.26
4.8%
Planned (10b5-1)
4 Feb 2026
Yi Steven See Remarks
Sold on a plan
$35.75K 4,000 at 8.94
0.1%
Planned (10b5-1)
4 Feb 2026
MAETZOLD DEREK J Pres. & Chief Exec. Officer
Sold on a plan 2×
$31.04K 817 at 37.99
1.0%
Planned (10b5-1)
4 Feb 2026
Hamilton Brian T President of CCBX
Sold on a plan
$15.33K 171 at 89.67
0.2%
Planned (10b5-1)
4 Feb 2026
Spiegel Reuven Executive Vice President, DKL
Sold on a plan
$13.10K 250 at 52.38
1.1%
Planned (10b5-1)
4 Feb 2026
Rider Michael J Global General Counsel
Sold on a plan
$13.00K 50 at 260.00
0.5%
Planned (10b5-1)
4 Feb 2026
Glass Ronald W. VP & Chief Accounting Officer
Sold on a plan
$4.70K 3,313 at 1.42
1.0%
Planned (10b5-1)
4 Feb 2026
Marion Josh R. SVP and General Counsel
Sold on a plan
$4.66K 3,284 at 1.42
1.7%
Planned (10b5-1)
3 Feb 2026
Morris Donna Executive Vice President
Sold on a plan
$9.43M 76,181 at 123.79
15.9%
Planned (10b5-1)
3 Feb 2026
Quirk Steven M. Chief Brokerage Officer
Sold on a plan 6×
$4.61M 52,540 at 87.81
65.6%
Sold half or more
3 Feb 2026
Biswas Sanjit CHIEF EXECUTVE OFFICER · indirect
Sold on a plan 3×
$1.41M 55,819 at 25.23
45.0%
Planned (10b5-1)
3 Feb 2026
Bicket John SEE REMARKS · indirect
Sold on a plan 4×
$1.40M 55,364 at 25.23
44.8%
Planned (10b5-1)
3 Feb 2026
Roberts Chad EVP, Production Solutions
Sold on a plan
$1.22M 54,706 at 22.39
44.9%
Planned (10b5-1)
3 Feb 2026
Reynal Vicente See Remarks
Sold on a plan
$913.62K 9,719 at 94.00
4.8%
Planned (10b5-1)
3 Feb 2026
Gallagher Daniel Martin Jr Chief Legal Officer
Sold on a plan 6×
$870.66K 10,000 at 87.07
2.5%
Planned (10b5-1)
3 Feb 2026
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan 2×
$830.28K 3,594 at 231.02
2.0%
Planned (10b5-1)
3 Feb 2026
Guyer William Chief Development Officer
Sold on a plan
$817.33K 20,000 at 40.87
94.2%
Sold half or more
3 Feb 2026
Hayne Margaret Co-President & CCO · indirect
Sold on a plan 2×
$675.54K 9,333 at 72.38
0.5%
Planned (10b5-1)
3 Feb 2026
Hunsaker Craig E EVP, PEOPLE & CULTURE
Sold on a plan
$549.54K 37,358 at 14.71
3.1%
Planned (10b5-1)
3 Feb 2026
ROTE WILLIAM E. Chief Research Officer
Sold on a plan
$409.10K 12,446 at 32.87
10.2%
Planned (10b5-1)
3 Feb 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$378.23K 1,639 at 230.77
1.2%
Planned (10b5-1)
3 Feb 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$307.84K 1,334 at 230.77
0.6%
Planned (10b5-1)
3 Feb 2026
Singh Ritadhwaja Jebens EVP & CHIEF DIGITAL OFFICER
Sold on a plan
$178.22K 5,880 at 30.31
5.4%
Planned (10b5-1)
3 Feb 2026
ROBINS HARLAN S Chief Scientific Officer
Sold on a plan
$154.28K 8,120 at 19.00
0.7%
Planned (10b5-1)
3 Feb 2026
FISHER ERIKA ASHLEY Chief Legal Officer
Sold on a plan
$148.36K 589 at 251.88
5.1%
Planned (10b5-1)
3 Feb 2026
MAETZOLD DEREK J Pres. & Chief Exec. Officer
Sold on a plan
$127.72K 3,200 at 39.91
3.6%
Planned (10b5-1)
3 Feb 2026
Indelicarto Thomas C EVP, Gen Counsel & Secretary
Sold on a plan 2×
$124.04K 498 at 249.08
1.6%
Planned (10b5-1)
3 Feb 2026
Flammer Martina M.D. Chief Medical Officer
Sold on a plan
$123.84K 795 at 155.77
0.9%
Planned (10b5-1)
3 Feb 2026
Foehr David Senior VP, Finance and PAO
Sold on a plan 2×
$111.12K 5,556 at 20.00
22.7%
Planned (10b5-1)
3 Feb 2026
Sold on a plan 2×
$109.90K 10,000 at 10.99
0.5%
Planned (10b5-1)
3 Feb 2026
Sold on a plan
$96.50K 10,500 at 9.19
14.4%
Planned (10b5-1)
3 Feb 2026
Schulz Tamara L Chief Accounting Officer
Sold on a plan
$91.31K 1,527 at 59.80
1.5%
Planned (10b5-1)
3 Feb 2026
Smith Chad M. Pres & COO, Better Mortgage · indirect
Sold on a plan
$83.80K 3,097 at 27.06
14.3%
Planned (10b5-1)
3 Feb 2026
Yi Steven See Remarks
Sold on a plan
$80.33K 8,000 at 10.04
0.3%
Planned (10b5-1)
3 Feb 2026
Lorrain Daniel S. Chief Scientific Officer
Sold on a plan 2×
$62.31K 4,170 at 14.94
2.6%
Planned (10b5-1)
3 Feb 2026
WESTBROOKS KRISTOPHER R President & COO
Sold on a plan
$62.06K 2,951 at 21.03
1.5%
Planned (10b5-1)
3 Feb 2026
SCHRAMM LYRA AMBER Chief People Officer
Sold on a plan
$55.99K 199 at 281.37
52.9%
Sold half or more
3 Feb 2026
Charlton Rebecca L SVP, Controller & CAO
Sold on a plan
$47.49K 843 at 56.34
5.7%
Planned (10b5-1)
Showing 8,001–8,050 of 10,581. ← Newer Page 161 of 212 Older →